Search Results 651-660 of 16073 for actinic keratosis clinical trials
Clinical Trials · A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301).
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer. Participation eligibility. Participant eligibility ...
About this study. The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients ...
The GUARD Trial is a multi-center adaptive Phase 3 clinical trial of repeated intravitreal injections of ADX-2191 for the prevention of proliferative ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
The purpose of this study is to investigate the occurrance and disease characteristics of chronic hives lasting longer than 6 weeks and that do not have an ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
The purpose of this study is to determine the feasibility of the remote chemotherapy management and patient monitoring platform GHoST Protocol among patients ...
The trial is designed as a randomized, placebo-controlled study with men randomized to receiving no therapy or penile traction therapy 30 minutes once, twice, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.